Improvement in Itch and Other Psoriasis Symptoms With Brodalumab in Phase 3 Randomized Controlled Trials

ConclusionBrodalumab demonstrated rapid, robust improvements in symptoms assessed by the PSI, including itch, vs placebo and ustekinumab.This article is protected by copyright. All rights reserved.

Source: Journal of the European Academy of Dermatology and Venereology - March 6, 2018 Category: Dermatology Authors: A.B. Gottlieb, K. Gordon, S. Hsu, B. Elewski, L.F. Eichenfield, L. Kircik, S. Rastogi, R. Pillai, R. Israel Tags: Original Article Source Type: research